Stay updated on AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page.

Latest updates to the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a clinical study evaluating the safety and efficacy of AFM24 in combination with SNK01, while adding new information about the study's interventional model and collaborators.SummaryDifference30%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page.